AlphaFold predicted structure
SPRY1 · O43609

Mean pLDDT
62.1/ 100
Low
319 residues
Confidence breakdown
- Very high(≥ 90)14%
- Confident(70–90)27%
- Low(50–70)13%
- Very low(< 50)46%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
sprouty RTK signaling antagonist 1
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Rare syndromic craniosynostosis or isolated multisuture synostosis
BIALLELIC, autosomal or pseudoautosomalCAKUT
DDG2P
BIALLELIC, autosomal or pseudoautosomalUnexplained kidney failure in young people
Unexplained young onset end-stage renal disease - additional genes
Unknownneurodegenerative disease
Barrett esophagus
chronic hepatitis
esophageal adenocarcinoma
ovarian dysfunction
hypertensive disorder
hereditary disease
peptic ulcer disease
cervical carcinoma
androgenetic alopecia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Protein sprouty homolog 1
Inhibits fibroblast growth factor (FGF)-induced retinal lens fiber differentiation, probably by inhibiting FGF-mediated phosphorylation of ERK1/2 (By similarity). Inhibits TGFB-induced epithelial-to-mesenchymal transition in lens epithelial cells (By similarity)
SPRY1 · O43609

Mean pLDDT
62.1/ 100
Low
319 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0